352 related articles for article (PubMed ID: 20540416)
1. Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery.
Merritt BG; Snow SN; Longley BJ
Cutis; 2010 May; 85(5):254-8. PubMed ID: 20540416
[TBL] [Abstract][Full Text] [Related]
2. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
Sellheyer K; Nelson P; Kutzner H; Patel RM
J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
Evangelista MT; North JP
J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
[TBL] [Abstract][Full Text] [Related]
4. Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?
Mohanty SK; Sardana R; McFall M; Pradhan D; Usmani A; Jha S; Mishra SK; Sampat NY; Lobo A; Wu JM; Balzer BL; Frishberg DP
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):273-277. PubMed ID: 35384877
[TBL] [Abstract][Full Text] [Related]
5. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
Katona TM; Perkins SM; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):174-9. PubMed ID: 18190441
[TBL] [Abstract][Full Text] [Related]
6. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
Jedrych J; McNiff JM
Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor.
Bartoš V
Acta Dermatovenerol Croat; 2019 Dec; 27(4):282-284. PubMed ID: 31969246
[TBL] [Abstract][Full Text] [Related]
8. Microcystic adnexal carcinoma: an immunohistochemical reappraisal.
Hoang MP; Dresser KA; Kapur P; High WA; Mahalingam M
Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.
Abbas O; Richards JE; Mahalingam M
Mod Pathol; 2010 Nov; 23(11):1535-43. PubMed ID: 20711172
[TBL] [Abstract][Full Text] [Related]
10. Merkel cells and sclerosing epithelial neoplasms.
Abesamis-Cubillan E; El-Shabrawi-Caelen L; LeBoit PE
Am J Dermatopathol; 2000 Aug; 22(4):311-5. PubMed ID: 10949455
[TBL] [Abstract][Full Text] [Related]
11. Microcystic adnexal carcinoma. Ten cases treated by Mohs micrographic surgery.
Burns MK; Chen SP; Goldberg LH
J Dermatol Surg Oncol; 1994 Jul; 20(7):429-34. PubMed ID: 8034836
[TBL] [Abstract][Full Text] [Related]
12. Ln-γ 2 chain of laminin-332 is a useful marker in differentiating between benign and malignant sclerosing adnexal neoplasms.
Koga K; Anan T; Fukumoto T; Fujimoto M; Nabeshima K
Histopathology; 2020 Jan; 76(2):318-324. PubMed ID: 31429981
[TBL] [Abstract][Full Text] [Related]
13. An Aggressive Microcystic Adnexal Carcinoma Infiltrating the Sternum.
Sandoval LF; Steinman H
J Drugs Dermatol; 2017 Feb; 16(2):180-181. PubMed ID: 28300863
[TBL] [Abstract][Full Text] [Related]
14. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin.
East E; Fullen DR; Arps D; Patel RM; Palanisamy N; Carskadon S; Harms PW
Am J Dermatopathol; 2016 Oct; 38(10):744-50. PubMed ID: 27043336
[TBL] [Abstract][Full Text] [Related]
15. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
Mitcov M; Scrivener Y; Cribier B
Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
[TBL] [Abstract][Full Text] [Related]
16. Panel vs. single marker for discriminating desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma.
Vollmer RT
J Cutan Pathol; 2009 Feb; 36(2):283; author reply 284. PubMed ID: 19208081
[No Abstract] [Full Text] [Related]
17. Benign subclinical syringomatous proliferations adjacent to a microcystic adnexal carcinoma: a tumor mimic with significant patient implications.
Boos MD; Elenitsas R; Seykora J; Lehrer MS; Miller CJ; Sobanko J
Am J Dermatopathol; 2014 Feb; 36(2):174-8. PubMed ID: 24061399
[TBL] [Abstract][Full Text] [Related]
18. Microcystic Adnexal Carcinoma and a Summary of Other Rare Malignant Adnexal Tumours.
Aslam A
Curr Treat Options Oncol; 2017 Aug; 18(8):49. PubMed ID: 28681209
[TBL] [Abstract][Full Text] [Related]
19. Metastatic microcystic adnexal carcinoma in an immunocompromised patient.
Carroll P; Goldstein GD; Brown CW
Dermatol Surg; 2000 Jun; 26(6):531-4. PubMed ID: 10848932
[TBL] [Abstract][Full Text] [Related]
20. Microcystic adnexal carcinoma: an often misdiagnosed, locally aggressive growing skin tumor.
Fischer S; Breuninger H; Metzler G; Hoffmann J
J Craniofac Surg; 2005 Jan; 16(1):53-8. PubMed ID: 15699645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
